Health News & Analysis

Novo Nordisk slashed the price of Wegovy by more than half on Wednesday amid a bitter rivalry with Hims & Hers Health.
The post Hims Stock Claws Back After Novo Nordisk Undercuts It With A Cheaper Wegovy appeared first on Investor's Business …

The US Dollar extended its intense sell-off on Tuesday, retreating to levels last seen in early December as investors remained concerned over the health of the US economy ahead of key data releases in the US labour market.

Over the past two weeks, a series of actions by Robert F. Kennedy Jr.’s Department of Health and Human Services (HHS) has seemed to validate the concerns of those who warned about having an outspoken vaccine skeptic in the nation’s leading healt…

During this time of heightened market volatility, it pays to be invested in the right places.

Offloading the Punta Gorda facility is expected to remove uncertainty tied to restoration costs and revenue losses for CYH.

OPCH and LMAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 4, 2025.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here is how Agilon Health (AGL) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.

OPCH, LMAT, C, FFIN and IBCP have been added to the Zacks Rank #1 (Strong Buy) List on March 4, 2025.

In the most recent trading session, UnitedHealth Group (UNH) closed at $467.05, indicating a -1.67% shift from the previous trading day.

Johnson & Johnson (JNJ) reachead $167.28 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.

Government spending is traditionally included in the GDP because changes in taxes, spending, deficits and regulations by the government can impact the path of overall growth.

Doing so could potentially complicate or distort a fundamental measure of the U.S. economy’s health.

Angst over the health of the U.S. economy has investors nervous about the possibility of an approaching recession — and the next big jobs report may not be enough to calm nerves for very long.

Aviron’s home fitness equipment operates on a simple principle: People hate working out. But many of those same people love playing video games. Perhaps the only thing standing between them and a more active lifestyle is some health competition and wel…

Dek: The health supplement company counts investors like Lewis Hamilton and Alex Honnold.

Kat Cole is no stranger to a career pivot. At Hooters, she went from waitress to vice president as she worked her way up the restaurant chain’s corporat…

Universal Health Realty’s net income and FFO increase in fourth-quarter 2024, driven by higher property income despite increased interest expenses.

School student records. Federal government data. Health records and more. Expect an unprecedented year for data breaches.
© 2024 TechCrunch. All rights reserved. For personal use only.

Should investors be excited or worried when a stock’s 50 -day simple moving average crosses above the 200-day simple moving average?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Glaukos reported robust fourth-quarter revenues, but shares plunged 24.8% post-earnings. Can expanding iDose TR adoption and global growth offset competitive pressures and valuation concerns in 2025?

Clover Health’s fourth-quarter 2024 results continue to benefit from the strength of its strong member retention. Strong revenue outlook bodes well.